Microphotograph of iPSC-derived dopamine neurons

About:

Maxim is a research coordinator at "HUMAN BRAIN DEVELOPMENT, EVOLUTION AND NEURODEVELOPMENTAL DISEASES" lab. Maxim  has received his PhD in genetics from the University of Helsinki in 2010, focusing on neurotrophic factors under the guidance of Professor Saarma. He played a pivotal role in the establishment of the High-Throughput Biology Unit at FIMM, University of Helsinki. Following this, Maxim was awarded the Sigrid Juselius postdoctoral fellowship in 2012, which led him to the San Raffaele Institute in Milan, Italy, where he studied in vivo reprogramming of glia into dopaminergic neurons. After returning to Finland, Maxim joined Professor Otonkoski’s team and engaged in cell reprogramming using CRISPR-activators and modeling early human caudal brain development with brain organoids. In 2019, he joined Professor Suomalainen-Wartiovaara’s team to study mitochondrial diseases using neurons derived from patients’ stem cells. In 2022, Maxim joined Takashi Namba’s group to research the metabolic vulnerabilities of human glioblastoma and the metabolic aspects of early human neurogenesis.

Contact Details

Maxim Bespalov
Haartmaninkatu 8
FIN-00290 Helsinki

 
maxim.bespalov aт helsinki.fi

Education

University of Helsinki

PhD  January 2010

Department of Genetics, Faculty of Biological and Environmental Sciences, University of Helsinki, Finland. 

PhD supervisor – Prof. Mart Saarma. 

Title: GDNF Receptors: Veterans and Novices

Moscow State University

Master of Science June 1998

Department of Soil Biology, Soil Science Department, Moscow State University, Russia

Work

University of Helsinki

Research Coordinator  March 2022 - Present

I primarily work on interrogating glioblatoma metabolism, looking for the ways to find glioblastoma vulnerabilities at Takashi Namba's Lab at Neuroscience Center, University of Helsinki

Skills

Cell reprogramming in vitro and in vivo (brain), human and mouse iPS cells generation and maintenance, neural stem cells and differentiation, brain organoids, CRISPR-mediated genome editing (knock-in), CRISPR/dCas9 gene induction, Ca2+ imaging (brain slices and 2D cultures), cell-based and biochemical assays development, laboratory automation and high-throughput screening, molecular cloning, lentiviruses, work with animals (including intracranial operations on living animals), microscopy (light and electron), immunological methods for molecules detection (IC, IHC, WB), protein expression and purification (E. coli, insect, mammalian), protein chemistry, radiological methods of molecules detection (including proteins iodination), gene expression analysis (RNA-seq data analysis, Northern analysis, RT-PCR, whole mount in situ hybridization), molecular simulations, docking and modeling, computational chemistry, R-language, Shiny apps .